UBS Group’s PepperLime Health Acquisition Corporation Unit PEPLU Stock Holding History

UBS Group’s Portfolio PEPLU Stock Details PEPLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-187	Closed	-$1.89K	–	11612
2022 Q4	$1.89K	Buy	+187	New	+$1.87K	﹤0.01%	9770
2022 Q3	–	Sell	-80	Closed	-$1K	–	11857
2022 Q2	$1K	Buy	+80	New	+$801	﹤0.01%	10208

Other funds holding PEPLU

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group's PEPLU Position: Q1 2023 in Review

UBS Group sold out of PepperLime Health Acquisition Corporation Unit (PEPLU) in Q1 2023, closing a stake of 187 shares — an estimated $1.89K sold.

UBS Group first reported a position in PEPLU in Q2 2022 and held it in 2 quarters. The position peaked at $1.89K in Q4 2022. 1 fund tracked by Wall St. Rank holds PEPLU as of Q1 2023.

UBS Group reported no remaining PepperLime Health Acquisition Corporation Unit position as of Q1 2023 after selling out during the quarter.
UBS Group sold 187 PepperLime Health Acquisition Corporation Unit shares in Q1 2023, an estimated $1.89K.
UBS Group first reported a position in PepperLime Health Acquisition Corporation Unit in Q2 2022 and held it in 2 quarters.
UBS Group's PepperLime Health Acquisition Corporation Unit position peaked at $1.89K in Q4 2022.
1 fund tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Unit as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.